Coronary allograft vasculopathy managed by Flash ostial balloon in a pediatric patient

Viral K Desai1, Mohammad Mathbout2, Apurv Agarwal1

  • 1Department of Internal Medicine, University of Louisville, Louisville KY.

Insights

Coronary allograft vasculopathy (CAV) is a major risk for heart transplant recipients. This case report details a novel percutaneous coronary intervention for pediatric CAV, offering potential for improved outcomes.

Area of Science:

  • Cardiology
  • Transplantation immunology
  • Pediatric cardiology

Background:

  • Coronary allograft vasculopathy (CAV) is a leading cause of death in heart transplant recipients, characterized by intimal hyperplasia, atherosclerosis, and inflammation.
  • Diagnosis of obstructive CAV can be challenging due to asymptomatic presentation in post-transplant patients.
  • The efficacy of percutaneous coronary intervention (PCI) for pediatric CAV remains understudied.

Observation:

  • This report presents the first-in-human use of a Flash ostial balloon for stent flaring.
  • The intervention was performed in a pediatric patient with a history of orthotopic heart transplant.
  • The patient had ostial left main coronary artery disease, a manifestation of CAV.

Findings:

  • Successful management of ostial left main coronary artery disease in a pediatric heart transplant recipient using a novel PCI technique.
  • The use of a Flash ostial balloon for flaring an ostial coronary stent was demonstrated.
  • This approach addressed a challenging manifestation of coronary allograft vasculopathy.

Implications:

  • This case suggests a potential new therapeutic option for pediatric patients with CAV.
  • Further research is warranted to evaluate the long-term efficacy and safety of this PCI technique in pediatric heart transplant recipients.
  • This intervention may improve outcomes and recovery for young patients suffering from CAV.